Tuesday, January 26, 2021  | 11 Jamadilakhir, 1442
Samaa TV
Facebook Twitter Youtube
HOME > Health

Plasma therapy trial for COVID-19 begins at Karachi’s AKU

The trial will evaluate benefits and safety of plasma therapy

SAMAA | - Posted: May 19, 2020 | Last Updated: 8 months ago
Posted: May 19, 2020 | Last Updated: 8 months ago
Plasma therapy trial for COVID-19 begins at Karachi’s AKU

Photo: AFP

A new clinical trial evaluating the benefits and safety of plasma therapy, an emerging form of treatment, in COVID-19 patients is underway at the Aga Khan University in Karachi.

Convalescent plasma therapy involves separating blood donated by previous COVID-19 patients into plasma, a clear straw-coloured liquid, that contains antibodies and proteins that help fight infections.

The plasma is then injected into a severely ill patient whose immune system may not be able to generate the antibodies needed to combat the virus. A single donation can potentially treat two patients.

Researchers will perform three pre-procedural investigations on each donor to ensure their blood is safe and to check their suitability for apheresis, the process which collects plasma. Like a typical blood donation, the process is painless after the initial prick and lasts around two hours.

Once plasma is transfused into a patient, the team will monitor the response to the treatment and assess its effectiveness through clinical and laboratory tests. Informed consent will be sought from all potential donors as well as those receiving the treatment, the AKU said in a statement.

“Plasma therapy can potentially help treat patients with moderate to severe COVID-19 infection,” said Dr Natasha Ali, who is part of a team of six faculty members from the departments of Pathology and Laboratory Medicine and Internal Medicine, working on the trial.

“This trial is part of the University’s science-based approach to evaluating novel treatments that can help save lives during this pandemic.”

There is currently no vaccine for the novel coronavirus and no approved form of treatment beyond managing its symptoms. The trial will generate evidence on whether plasma therapy, the only experimental treatment currently available for the virus, can help treat those suffering from acute complications from the virus.

The University is also participating in Solidarity, the international clinical trial launched by the World Health Organisation and its partners, to find effective treatments for the coronavirus.

The study has been approved by the Drug Regulatory Authority of Pakistan and Pakistan’s National Bioethics Committee.

FaceBook WhatsApp

Tell us what you think:

Your email address will not be published.

FaceBook WhatsApp

coronavirus vaccine pakistan news today, coronavirus vaccine trials in pakistan, bcg vaccine pakistan coronavirus, astrazeneca covid vaccine approval, astrazeneca vaccine update, astrazeneca vaccine approval, astrazeneca covid vaccine efficacy, astrazeneca vaccine type, astrazeneca vaccine vs pfizer, astrazeneca vaccine usa, astrazeneca vaccine india, oxford university-astrazeneca covid-19 vaccine status, sinopharm vs pfizer, sinovac vaccine efficacy, sinovac vs pfizer vaccine

Lahore administration demolishes part of Khokhar Palace
Rawalpindi man hit by train while ‘filming TikTok’
COVID-19 vaccine updates in Pakistan and around the world
Pak Suzuki fails to deliver Cultus, Swift over supply issues
NADRA to issue succession certificates in two weeks
Watch: Rana Sanaullah makes a roaring entry to Lahore court
Karachi braces for another cold wave, Siberian winds in city
Traffic plan for JUI-F’s anti-Israel march in Karachi
New cold wave entering Karachi this week: Met dept
About Us   |   Anchor Profiles   |   Online Advertising   |   Contact Us   |   Feedback   |   Apps   |   FAQs   |   Authors   |   Comment Policy
Facebook   |   Twitter   |   Instagram   |   YouTube   |   WhatsApp